Compare NIM & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NIM | CBUS |
|---|---|---|
| Founded | 1992 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.7M | 121.1M |
| IPO Year | N/A | 2017 |
| Metric | NIM | CBUS |
|---|---|---|
| Price | $9.29 | $1.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 14.8K | ★ 602.3K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.80 | $1.09 |
| 52 Week High | $9.94 | $4.19 |
| Indicator | NIM | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 40.02 | 44.59 |
| Support Level | $9.23 | $1.43 |
| Resistance Level | $9.44 | $1.82 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 16.07 | 85.29 |
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.